Literature DB >> 2638179

Triclosan: a safety profile.

S J DeSalva, B M Kong, Y J Lin.   

Abstract

Triclosan (2, 4, 4'-trichloro-2'-hydroxydiphenyl ether), an antimicrobial agent, has been used extensively for 20 years in consumer products, principally in deodorants, soaps and other dermatological preparations. Recently, the use of triclosan has been extended to oral health care products such as dentifrices. This paper reviews safety information, both pre-clinical and clinical studies, from the literature, data submitted to the Antimicrobial I OTC Review Panel and unpublished work from the Pharmacology and Toxicology Department of the Colgate-Palmolive Company. The data spans acute, subacute, subchronic and chronic toxicity; mutagenicity, carcinogenicity, reproduction/teratology and pharmacokinetics. Results of these studies show that triclosan is well tolerated by a variety of species including man. In clinical studies with triclosan in solutions and dentifrices, a steady state was reached by day 7 with blood levels in the parts per billion (ppb) range and urine as the main route of excretion. Based on these studies, triclosan can be considered safe for use in dentifrice and mouthrinse products.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2638179

Source DB:  PubMed          Journal:  Am J Dent        ISSN: 0894-8275            Impact factor:   1.522


  19 in total

1.  Urinary triclosan concentrations and semen quality among men from a fertility clinic.

Authors:  Feiby L Nassan; Lidia Mínguez-Alarcón; Paige L Williams; Ramace Dadd; John C Petrozza; Jennifer B Ford; Antonia M Calafat; Russ Hauser
Journal:  Environ Res       Date:  2019-08-06       Impact factor: 6.498

2.  Investigations of immunotoxicity and allergic potential induced by topical application of triclosan in mice.

Authors:  Stacey E Anderson; B Jean Meade; Carrie M Long; Ewa Lukomska; Nikki B Marshall
Journal:  J Immunotoxicol       Date:  2015-03-27       Impact factor: 3.000

3.  Attenuated virulence and biofilm formation in Staphylococcus aureus following sublethal exposure to triclosan.

Authors:  Joe Latimer; Sarah Forbes; Andrew J McBain
Journal:  Antimicrob Agents Chemother       Date:  2012-03-19       Impact factor: 5.191

Review 4.  Occurrence and toxicity of antimicrobial triclosan and by-products in the environment.

Authors:  Gilles Bedoux; Benoit Roig; Olivier Thomas; Virginie Dupont; Barbara Le Bot
Journal:  Environ Sci Pollut Res Int       Date:  2011-11-05       Impact factor: 4.223

Review 5.  Triclosan exposure, transformation, and human health effects.

Authors:  Lisa M Weatherly; Julie A Gosse
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2017       Impact factor: 6.393

Review 6.  Antimicrobial sutures and prevention of surgical site infection: assessment of the safety of the antiseptic triclosan.

Authors:  David Leaper; Ojan Assadian; Nils-Olaf Hubner; Andrew McBain; Thomas Barbolt; Stephen Rothenburger; Peter Wilson
Journal:  Int Wound J       Date:  2011-08-19       Impact factor: 3.315

7.  Synthesis and application of triclosan methacrylate monomer in resin composites.

Authors:  Andreia Bolzan de Paula; Jesus Roberto Taparelli; Roberta Caroline Bruschi Alonso; Lúcia Helena Innocentini-Mei; Regina M Puppin-Rontani
Journal:  Clin Oral Investig       Date:  2018-06-18       Impact factor: 3.573

Review 8.  Triclosan: A Widespread Environmental Toxicant with Many Biological Effects.

Authors:  Mei-Fei Yueh; Robert H Tukey
Journal:  Annu Rev Pharmacol Toxicol       Date:  2016       Impact factor: 13.820

9.  Triclosan as a systemic antibacterial agent in a mouse model of acute bacterial challenge.

Authors:  Shilpi Sharma; T N C Ramya; Avadhesha Surolia; Namita Surolia
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

10.  Absorption, pharmacokinetics, and safety of triclosan after dermal administration.

Authors:  Christian Queckenberg; Jürgen Meins; Bertil Wachall; Oxana Doroshyenko; Dorota Tomalik-Scharte; Bärbel Bastian; Mona Abdel-Tawab; Uwe Fuhr
Journal:  Antimicrob Agents Chemother       Date:  2009-10-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.